207 related articles for article (PubMed ID: 17315533)
41. [Value of serum fibroblast growth factor 23 in diagnosis of hypophosphatemic rickets in children].
Dong SS; Che RC; Zheng BX; Zhang AH; Wang CL; Bai M; Chen Y
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jul; 25(7):705-710. PubMed ID: 37529952
[TBL] [Abstract][Full Text] [Related]
42. Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans.
Imel EA; Peacock M; Gray AK; Padgett LR; Hui SL; Econs MJ
J Clin Endocrinol Metab; 2011 Nov; 96(11):3541-9. PubMed ID: 21880793
[TBL] [Abstract][Full Text] [Related]
43. FGF23-related hypophosphatemic rickets preceding the onset of systemic lupus erythematosus: A juvenile case.
Tabei Y; Ohtsu Y; Shimada M; Wada A; Hamajima E; Osawa Y; Takizawa T
Clin Case Rep; 2024 Jan; 12(1):e8420. PubMed ID: 38223518
[TBL] [Abstract][Full Text] [Related]
44. Clinical and molecular heterogeneity in a large series of patients with hypophosphatemic rickets.
Capelli S; Donghi V; Maruca K; Vezzoli G; Corbetta S; Brandi ML; Mora S; Weber G
Bone; 2015 Oct; 79():143-9. PubMed ID: 26051471
[TBL] [Abstract][Full Text] [Related]
45. The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk.
Pastor-Arroyo EM; Gehring N; Krudewig C; Costantino S; Bettoni C; Knöpfel T; Sabrautzki S; Lorenz-Depiereux B; Pastor J; Strom TM; Hrabě de Angelis M; Camici GG; Paneni F; Wagner CA; Rubio-Aliaga I
Kidney Int; 2018 Jul; 94(1):49-59. PubMed ID: 29735309
[TBL] [Abstract][Full Text] [Related]
46. Hypophosphatemia: the common denominator of all rickets.
Tiosano D; Hochberg Z
J Bone Miner Metab; 2009; 27(4):392-401. PubMed ID: 19504043
[TBL] [Abstract][Full Text] [Related]
47. [Rickets/Osteomalacia. Anti-FGF23 antibody therapy in patients with FGF23-related hypophosphatemic rickets and osteomalacia.].
Kinoshita Y
Clin Calcium; 2018; 28(10):1373-1379. PubMed ID: 30269120
[TBL] [Abstract][Full Text] [Related]
48. FGF23 is elevated in Gambian children with rickets.
Prentice A; Ceesay M; Nigdikar S; Allen SJ; Pettifor JM
Bone; 2008 Apr; 42(4):788-97. PubMed ID: 18234575
[TBL] [Abstract][Full Text] [Related]
49. [Fibroblast growth factor (FGF) 23 works as a phosphate-regulating hormone and is involved in the pathogenesis of several disorders of phosphate metabolism].
Fukumoto S
Rinsho Byori; 2007 Jun; 55(6):555-9. PubMed ID: 17657990
[TBL] [Abstract][Full Text] [Related]
50. Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation.
Kruse K; Woelfel D; Strom TM
Horm Res; 2001; 55(6):305-8. PubMed ID: 11805436
[TBL] [Abstract][Full Text] [Related]
51. A clinical and molecular genetic study of hypophosphatemic rickets in children.
Cho HY; Lee BH; Kang JH; Ha IS; Cheong HI; Choi Y
Pediatr Res; 2005 Aug; 58(2):329-33. PubMed ID: 16055933
[TBL] [Abstract][Full Text] [Related]
52. Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment.
Ovejero D; Lim YH; Boyce AM; Gafni RI; McCarthy E; Nguyen TA; Eichenfield LF; DeKlotz CM; Guthrie LC; Tosi LL; Thornton PS; Choate KA; Collins MT
Osteoporos Int; 2016 Dec; 27(12):3615-3626. PubMed ID: 27497815
[TBL] [Abstract][Full Text] [Related]
53. FGF23 and Phosphate Wasting Disorders.
Huang X; Jiang Y; Xia W
Bone Res; 2013 Jun; 1(2):120-32. PubMed ID: 26273497
[TBL] [Abstract][Full Text] [Related]
54. [Bone and Calcium Research Update 2015. Novel treatment for FGF23-related hypophosphatemic diseases].
Fukumoto S
Clin Calcium; 2015 Jan; 25(1):37-44. PubMed ID: 25530521
[TBL] [Abstract][Full Text] [Related]
55. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
[TBL] [Abstract][Full Text] [Related]
56. Eldecalcitol Causes FGF23 Resistance for Pi Reabsorption and Improves Rachitic Bone Phenotypes in the Male Hyp Mouse.
Kaneko I; Segawa H; Ikuta K; Hanazaki A; Fujii T; Tatsumi S; Kido S; Hasegawa T; Amizuka N; Saito H; Miyamoto KI
Endocrinology; 2018 Jul; 159(7):2741-2758. PubMed ID: 29878089
[TBL] [Abstract][Full Text] [Related]
57. Regulation of phosphate homeostasis in infants, children, and adolescents, and the role of phosphatonins in this process.
Garabedian M
Curr Opin Pediatr; 2007 Aug; 19(4):488-91. PubMed ID: 17630616
[TBL] [Abstract][Full Text] [Related]
58. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A
Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
[TBL] [Abstract][Full Text] [Related]
59. [Rickets].
Yasuda T
Clin Calcium; 2009 Jan; 19(1):109-16. PubMed ID: 19122271
[TBL] [Abstract][Full Text] [Related]
60. Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia.
Shimizu Y; Tada Y; Yamauchi M; Okamoto T; Suzuki H; Ito N; Fukumoto S; Sugimoto T; Fujita T
Bone; 2009 Oct; 45(4):814-6. PubMed ID: 19555782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
